The present invention relates to the development of a novel vaccine candidate comprising of a conjugate vaccine alone or in combination with plasmid DNA or inactivated or live attenuated whole Brucella organism which can be used as a prophylactic or a therapeutic vaccine in target species such as cattle and buffaloes and as a differentiator between infected and vaccinated animals.